Evidence map›Paper›PMID 41112945›Full record

ReviewInternational journal of nanomedicine2025

The Application of Exosomes From Different Sources Loaded with Natural Small-Molecule Compounds in Disease.

Lulu Zhang, Changqi Shi, Lan Yan, Xiaomeng Zhang, Xinyu Ji, Li Li, Xiaojuan He, Yong Tan, Ning Zhao, Cheng Lu

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lulu Zhang *Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Changqi Shi *Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Lan Yan *Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Xiaomeng ZhangInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Xinyu JiInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Li LiInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Xiaojuan HeInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Yong TanInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Ning ZhaoInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Cheng LuInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.ORCID 0000-0002-6474-9198

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exosomes, as naturally derived nanoscale vesicles, possess inherent biological functions that make them highly efficient drug delivery vehicles. Their cellular origin dictates their bioactivity, targeting specificity, and regulatory effects, which are critical for therapeutic applications. Natural small-molecule compounds, despite their therapeutic potential, are often limited by poor solubility, instability, toxicity, and rapid clearance. Exosomes can overcome these limitations by enhancing drug stability, improving bioavailability, and enabling targeted delivery to disease sites, while also contributing therapeutic effects through their intrinsic biological properties. This review summarizes advances in the application of exosomes from diverse cellular sources for delivering natural compounds in the treatment of various diseases, and discusses the dual functional mechanisms of exosomes as both carriers and therapeutic agents, highlighting the advantages of integrating exosomes with natural small-molecule compounds. The review aims to explore novel strategies for improving the utilization of natural small-molecule compounds and to inspire new perspectives for the development of targeted nanomedicines in the future.

Indexed as

Biological ProductsDrug CarriersDrug Delivery SystemsExosomesAnimalsHumansNanomedicineBiological ProductsDrug Carrierscellular sourcesdisease treatmentdrug delivery systemsexosomenatural small-molecule compounds

Identifiers

PMID41112945
PMCPMC12531312

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.